APA (7th ed.) Citation

Damm, M., Efremov, L., Birnbach, B., Terrero, G., Kleeff, J., Mikolajczyk, R., . . . Krug, S. (2021). Efficacy and Safety of Neoadjuvant Gemcitabine Plus Nab-Paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Cancer—A Systematic Review and Meta-Analysis. Cancers, 13(17), 4326. https://doi.org/10.3390/cancers13174326

Chicago Style (17th ed.) Citation

Damm, Marko, Ljupcho Efremov, Benedikt Birnbach, Gretel Terrero, Jörg Kleeff, Rafael Mikolajczyk, Jonas Rosendahl, Patrick Michl, and Sebastian Krug. "Efficacy and Safety of Neoadjuvant Gemcitabine Plus Nab-Paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Cancer—A Systematic Review and Meta-Analysis." Cancers 13, no. 17 (2021): 4326. https://doi.org/10.3390/cancers13174326.

MLA (9th ed.) Citation

Damm, Marko, et al. "Efficacy and Safety of Neoadjuvant Gemcitabine Plus Nab-Paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Cancer—A Systematic Review and Meta-Analysis." Cancers, vol. 13, no. 17, 2021, p. 4326, https://doi.org/10.3390/cancers13174326.